Recent News: GenomeSmart and ASPiRA LABS, a Vermillion Company, Launch Pilot Program to Improve Access to Genetic Testing


CONTACT US to learn more or sign up for email alerts.

Our Products

How We’re Transforming Ovarian Cancer Detection

We concentrate our development of novel diagnostic tests for gynecologic disease, with an initial focus on ovarian cancer.